These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34861139)

  • 1. Fighting the Fiber: Targeting Collagen in Lung Fibrosis.
    Staab-Weijnitz CA
    Am J Respir Cell Mol Biol; 2022 Apr; 66(4):363-381. PubMed ID: 34861139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
    Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomic profiling of extracellular matrix and site-specific collagen post-translational modifications in an
    Merl-Pham J; Basak T; Knüppel L; Ramanujam D; Athanason M; Behr J; Engelhardt S; Eickelberg O; Hauck SM; Vanacore R; Staab-Weijnitz CA
    Matrix Biol Plus; 2019 Feb; 1():100005. PubMed ID: 33543004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel profibrotic mechanism mediated by TGFβ-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells.
    Luo Y; Xu W; Chen H; Warburton D; Dong R; Qian B; Selman M; Gauldie J; Kolb M; Shi W
    J Pathol; 2015 Jul; 236(3):384-94. PubMed ID: 25779936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts.
    Bouros E; Filidou E; Arvanitidis K; Mikroulis D; Steiropoulos P; Bamias G; Bouros D; Kolios G
    Pulm Pharmacol Ther; 2017 Oct; 46():78-87. PubMed ID: 28865842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis.
    Kheirollahi V; Wasnick RM; Biasin V; Vazquez-Armendariz AI; Chu X; Moiseenko A; Weiss A; Wilhelm J; Zhang JS; Kwapiszewska G; Herold S; Schermuly RT; Mari B; Li X; Seeger W; Günther A; Bellusci S; El Agha E
    Nat Commun; 2019 Jul; 10(1):2987. PubMed ID: 31278260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of metabolic reprogramming and de novo amino acid synthesis in collagen protein production by myofibroblasts: implications for organ fibrosis and cancer.
    Hamanaka RB; Mutlu GM
    Amino Acids; 2021 Dec; 53(12):1851-1862. PubMed ID: 33963932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
    Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts.
    Satyanarayana G; Turaga RC; Sharma M; Wang S; Mishra F; Peng G; Deng X; Yang J; Liu ZR
    Theranostics; 2021; 11(19):9331-9341. PubMed ID: 34646373
    [No Abstract]   [Full Text] [Related]  

  • 11. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
    Pardo A; Selman M
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.
    Staab-Weijnitz CA; Fernandez IE; Knüppel L; Maul J; Heinzelmann K; Juan-Guardela BM; Hennen E; Preissler G; Winter H; Neurohr C; Hatz R; Lindner M; Behr J; Kaminski N; Eickelberg O
    Am J Respir Crit Care Med; 2015 Aug; 192(4):455-67. PubMed ID: 26039104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly.
    Knüppel L; Ishikawa Y; Aichler M; Heinzelmann K; Hatz R; Behr J; Walch A; Bächinger HP; Eickelberg O; Staab-Weijnitz CA
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):77-90. PubMed ID: 28257580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.
    Tjin G; White ES; Faiz A; Sicard D; Tschumperlin DJ; Mahar A; Kable EPW; Burgess JK
    Dis Model Mech; 2017 Nov; 10(11):1301-1312. PubMed ID: 29125826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
    Tumelty KE; Smith BD; Nugent MA; Layne MD
    J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of collagen-rich extracellular matrix on the intracellular delivery of glycol chitosan nanoparticles in human lung fibroblasts.
    Yhee JY; Yoon HY; Kim H; Jeon S; Hergert P; Im J; Panyam J; Kim K; Nho RS
    Int J Nanomedicine; 2017; 12():6089-6105. PubMed ID: 28860768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
    Liu G; Friggeri A; Yang Y; Milosevic J; Ding Q; Thannickal VJ; Kaminski N; Abraham E
    J Exp Med; 2010 Aug; 207(8):1589-97. PubMed ID: 20643828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CX3CL1 and CX3CR1 could be a relevant molecular axis in the pathophysiology of idiopathic pulmonary fibrosis.
    Rivas-Fuentes S; Herrera I; Salgado-Aguayo A; Buendía-Roldán I; Becerril C; Cisneros J
    Int J Med Sci; 2020; 17(15):2357-2361. PubMed ID: 32922201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP47: A Therapeutic Target in Pulmonary Fibrosis.
    Sakamoto N; Okuno D; Tokito T; Yura H; Kido T; Ishimoto H; Tanaka Y; Mukae H
    Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
    Im J; Kim K; Hergert P; Nho RS
    J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.